Bridget Beals
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Drug Discovery top 5%
Papers in
-
- Nanoparticle-Based Drug Delivery 3
- Oncology 2
- Cancer Treatment and Pharmacology 2
- Co-authors
- Neil P. Desai (5 shared papers)Andrew Jihoon Yang (5 shared papers)Vuong N. Trieu (4 shared papers)Michael Hawkins (2 shared papers)Tapas De (3 shared papers)Sherry Ci (4 shared papers)Patrick Soon‐Shiong (2 shared papers)Leslie G. Louie (3 shared papers)
- Journals
- Clinical Cancer Research (2 papers)Cancer Research (2 papers)Journal of Chromatography A (1 paper)The Journal of Physical Chemistry A (1 paper)
- Partner nations
- United States
In The Last Decade
Bridget Beals
6 papers receiving 1.5k citations
Bridget Beals's Hit Papers
Peers
Comparison fields: 5 of 78
- Biomaterials 766
- Drug Discovery 10
- Oncology 342
- Pharmaceutical Science 92
- Pulmonary and Respiratory Medicine 144
Countries citing papers authored by Bridget Beals
This map shows the geographic impact of Bridget Beals's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bridget Beals with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bridget Beals more than expected).
Fields of papers citing papers by Bridget Beals
This network shows the impact of papers produced by Bridget Beals. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bridget Beals. The network helps show where Bridget Beals may publish in the future.
Co-authors
The 16 scholars most cited alongside Bridget Beals, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Hit paper breakdown → | 2006 | 1027 |
| 2 | 2005 | 442 | |
| 3 | 1999 | 47 | |
| 4 | 2001 | 20 | |
| 5 | Nanoparticle albumin-bound (nab) rapamycin as an anticancer agent | 2007 | 5 |
| 6 | Pharmacokinetic and ADME study of nanoparticle albumin-bound 17AAG (nab-17AAG) in mice | 2008 | 2 |
About Bridget Beals
Bridget Beals is a scholar working on Biomaterials, Oncology, Food Science, Molecular Biology and Organic Chemistry, having authored 6 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), Cancer Treatment and Pharmacology (2 papers), PI3K/AKT/mTOR signaling in cancer (1 paper), Inorganic and Organometallic Chemistry (1 paper), Heat shock proteins research (1 paper), Coordination Chemistry and Organometallics (1 paper), Chemical Reaction Mechanisms (1 paper) and Polysaccharides Composition and Applications (1 paper). The work is most often cited by research in Biomaterials (766 citations), Drug Discovery (10 citations), Oncology (342 citations), Pharmaceutical Science (92 citations) and Pulmonary and Respiratory Medicine (144 citations). Bridget Beals has collaborated with scholars based in United States. Frequent co-authors include Neil P. Desai, Andrew Jihoon Yang, Vuong N. Trieu, Michael Hawkins, Tapas De, Sherry Ci, Patrick Soon‐Shiong, Leslie G. Louie, Zhiwen Yao and Donald J. Dykes. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Journal of Chromatography A and The Journal of Physical Chemistry A.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.